Professor Alicia Jenkins

Professor
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone 02 95625000
Fax 95621863

Curriculum vitae Curriculum vitae

Map

Selected grants

2014

  • FAME 1 - Eye; Jenkins A, Donaghue K, ONeal D, Best J; National Health and Medical Research Council (NHMRC)/Project Grants.
  • The role of residual beta-cell function on the risk of diabetes complications in children, adolescents and adults with type 1 diabetes; Cho Y, Donaghue K, Januszewski A, Jenkins A, Craig M, Benitez-Aguirre P; Diabetes Australia Research Trust/Diabetes Research Grant Program.
  • Purchase of the Retina Tomograph Platform with Corneal Confocal Microscope module; Keech A, Jenkins A; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • The protective effects of fenofibrate in diabetes-related susceptibility to ischaemia; Ng M, Jenkins A; National Health and Medical Research Council (NHMRC)/Project Grants.

2012

  • Testosterone intervention for the prevention of diabetes mellitus in high risk men: a randomised trial; Jenkins A, Wittert G; National Health and Medical Research Council (NHMRC)/Project Grants.

2011

  • Telehealth Facilitation of Diabetes and Cardiovascular Care in Australia; Bursell S, Jenkins A; University of Melbourne/Shared Research Support.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Jenkins, A., Breen, R., Lindsay, R., Brew, A. (2003). Reshaping Teaching In Higher Education: Linking Teaching With Research. UK: RoutledgeFalmer imprint of Taylor & Francis.

Journals

  • Jenkins, A., McBride, J., Liu, X., Zhang, B., Lee, K., Berry, W., Janknecht, R., Griffin, C., Aston, C., Lyons, T., Ma, J., et al (2014). Elevated Circulation Levels of an Antiangiogenic SERPIN in Patients with Diabetic Microvascular Complications Impair Wound Healing through Suppression of Wnt Signaling. The Journal of Investigative Dermatology, 134, 1725-1734. [More Information]
  • Jenkins, A. (2014). Sometimes you have to give a man a fish. Medical Journal of Australia, 200(2), 122-123. [More Information]
  • Vethakkan, S., Walters, J., Gooley, J., Boston, R., Kay, T., Goodman, D., Jenkins, A., Ward, G. (2014). The incretin response after successful islet transplantation. Transplantation, 97(2), e9-e11. [More Information]
  • Naser, N., Januszewski, A., Brown, B., Jenkins, A., Hill, M., Murphy, T. (2013). Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells. Frontiers in Physiology, 4, 1-14. [More Information]
  • Noonan, J., Jenkins, A., Ma, J., Keech, A., Wang, J., Lamoureux, E. (2013). An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes. Diabetes, 62(12), 3968-3975. [More Information]
  • Brown, B., Nobecourt, E., Zeng, J., Jenkins, A., Rye, K., Davies, M. (2013). Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages. PLoS One, 8(5), 1-9. [More Information]
  • Azar, M., Lyons, T., Alaupovic, P., Stoner, J., Quiroga, C., Kaufman, D., Lopes-Virella, M., Klein, R., Jenkins, A. (2013). Apolipoprotein-defined and NMR lipoprotein subclasses in the Veterans Affairs Diabetes Trial. Journal of Diabetes and Its Complications, 27(6), 627-632. [More Information]
  • Jenkins, A., Yu, J., Alaupovic, P., Basu, A., Klein, R., Lopes-Virella, M., Baker, N., Hunt, K., Lackland, D., Garvey, W., et al (2013). Apolipoprotein-defined lipoproteins and apolipoproteins: Associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Journal of Diabetes and Its Complications, 27(5), 447-453. [More Information]
  • Jenkins, A., ONeal, D. (2013). Dyslipidaemia in diabetes: a common problem worth treating to target. Endocrinology Today: peer reviewed updates for medical practitioners, 2(2), 24-29.
  • O'Neal, D., Adhya, S., Jenkins, A., Ward, G., Welsh, J., Voskanyan, G. (2013). Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set. Journal of diabetes science and technology, 7(2), 381-388.
  • Seller, D., Scibilia, R., Rodda, C., Jenkins, A. (2013). Growth in insulin pump use in Australian children with Type 1 Diabetes, and subsequent impact on a diabetes camp program. Infusystems Asia, 8(3), 25-30.
  • Hunt, K., Baker, N., Cleary, P., Backlund, J., Lyons, T., Jenkins, A., Virella, G., Lopes-Virella, M. (2013). Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes. Atherosclerosis, 231(2), 315-322. [More Information]
  • Alexander, K., Bryant, W., Cohen, N., Craig, M., Forbes, M., Fulcher, G., Greenaway, T., Harrison, N., Holmes-Walker, J., Howard, G., Jenkins, A., et al (2013). Provision of Quality Care for Adults with Type 1 Diabetes Requiring Insulin Pump Therapy (IIPT). Infusystems Asia, 8(1), 1-6.
  • Rasmussen, B., Hendrieckx, C., Clarke, B., Botti, M., Dunning, T., Jenkins, A., Speight, J. (2013). Psychosocial issues of women with type 1 diabetes transitioning to motherhood: a structured literature review. BMC Pregnancy and Childbirth, 13, 218. [More Information]
  • Samaras, K., Viardot, A., Lee, P., Jenkins, A., Botelho, N., Bakopanos, A., Lord, R., Hayward, C. (2013). Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance. Diabetes and Vascular Disease Research, 10(1), 40-48. [More Information]
  • Campbell, D., Somaratne, J., Jenkins, A., Prior, D., Yii, M., Kenny, J., Newcomb, A., Kelly, D., Black, M. (2013). Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. International Journal of Cardiology, 167(3), 1027-1237. [More Information]
  • Luke, J., Brown, A., Daniel, M., O'Dea, K., Best, J., Jenkins, A., Wang, Z., McDermott, R., Wang, Z., Rowley, K. (2013). Response to the Letter by Kawada et al. regarding the manuscript entitled "The metabolic syndrome and CVD outcomes for a central Australian cohort". Diabetes Research and Clinical Practice, 102(2), e22-e23. [More Information]
  • Du, M., Basu, A., Fu, D., Wu, M., Centola, M., Jenkins, A., Hanssen, K., Garg, S., Hammad, S., Scardo, J., et al (2013). Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care, 36(7), 2054-2061. [More Information]
  • Bursell, S., Jenkins, A., Brazionisb, L., Rowley, K., Brown, A. (2013). Telehealth in Australia: an evolution in health care services. Medical Journal of Australia, 199(1), 23-24. [More Information]
  • Luke, J., Brown, A., Daniell, M., O'Dea, K., Best, J., Jenkins, A., Wang, Z., McDermott, R., Wang, Z., Rowley, K. (2013). The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Research and Clinical Practice, 100(3), e70-e73. [More Information]
  • Chen, Y., Hu, Y., Lin, M., Jenkins, A., Keech, A., Mott, R., Lyons, T., Ma, J. (2013). Therapeutic Effects of PPARĪ± Agonists on Diabetic Retinopathy in Type 1 Diabetes Models. Diabetes, 62(1), 261-272. [More Information]
  • Jenkins, A., ONeal, D. (2013). What do insulin pumps offer in diabetes care? Endocrinology Today: peer reviewed updates for medical practitioners, 2(4), 27-30.
  • Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]
  • Campbell, D., Somaratne, J., Jenkins, A., Prior, D., Yii, M., Kenny, J., Newcomb, A., Schalkwijk, C., Black, M., Kelly, D. (2012). Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PLoS One, 7(11), e49813. [More Information]
  • Lopes-Virella, M., Jenkins, A., Baker, N., Virella, G., Hunt, K., Lyons, T., et al (2012). High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care, 35(6), 1333-1340. [More Information]
  • Ong, K., Rye, K., O'Connell, R., Jenkins, A., Brown, C., Xu, A., Sullivan, D., Barter, P., Keech, A. (2012). Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, 97(12), 4701-4708. [More Information]
  • Januszewski, A., Sachithanandan, N., Karschimkus, C., o'neal, D., Yeung, C., Alkatib, N., Jenkins, A. (2012). Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabetic Medicine, 29(6), 726-733. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Shaw, J., Jenkins, A., Wang, J. (2012). Novel versus traditional risk markers for diabetic retinopathy. Diabetologia: clinical and experimental diabetes and metabolism, 55(3), 666-670. [More Information]
  • Januszewski, A., Karschimkus, C., Davis, K., ONeal, D., Ward, G., Jenkins, A. (2012). Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: Assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Research and Clinical Practice, 95(1), e17-e19. [More Information]
  • Basu, A., Alaupovic, P., Wu, M., Jenkins, A., Yu, Y., Nankervis, A., Hanssen, K., Scholz, H., Henriksen, T., Lorentzen, B., et al (2012). Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. Journal of Clinical Endocrinology and Metabolism, 97(5), 1752-1762. [More Information]
  • Sasongko, M., Wong, T., Donaghue, K., Cheung, N., Jenkins, A., Benitez-Aguirre, P., Wang, J. (2012). Retinal Arteriolar Tortuosity is Associated With Retinopathy and Early Kidney Dysfunction in Type 1 Diabetes. American Journal of Ophthalmology, 153(1), 176-183. [More Information]
  • Benitez-Aguirre, P., Sasongko, M., Craig, M., Jenkins, A., Cusumano, J., Cheung, N., Wong, T., Donaghue, K. (2012). Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care, 35(3), 599-604. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Kawasaki, R., Jenkins, A., Shaw, J., Robinson, C., Wang, J. (2012). Serum Apolipoproteins are Associated With Systemic and Retinal Microvascular Function in People With Diabetes. Diabetes, 61(7), 1785-1792. [More Information]
  • Bursell, S., Brazionis, L., Jenkins, A. (2012). Telemedicine and ocular health in diabetes mellitus. Clinical & Experimental Optometry, 95(3), 311-327. [More Information]
  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2011). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(2), 280-290.
  • Tabet, F., Lambert, G., Torres, L., Hou, L., Sotirchos, I., Touyz, R., Jenkins, A., Barter, P., Rye, K. (2011). Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 1192-1200. [More Information]
  • Benitez-Aguirre, P., Craig, M., Sasongko, M., Jenkins, A., Wong, T., Wang, J., Cheung, N., Donaghue, K. (2011). Retinal Vascular Geometry Predicts Incident Retinopathy in Young People With Type 1 Diabetes. Diabetes Care, 34(7), 1622-1627. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Kawasaki, R., Jenkins, A., Shaw, J., Wang, J. (2011). Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids. Diabetes Care, 34(2), 474-479. [More Information]
  • Sasongko, M., Wang, J., Donaghue, K., Cheung, N., Benitez-Aguirre, P., Jenkins, A., Hsu, W., Lee, M., Wong, T. (2010). Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care, 33(6), 1331-1336. [More Information]
  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2010). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(2), 280-290. [More Information]
  • Chan, D., Hamilton, S., Rye, K., Chew, G., Jenkins, A., Lambert, G., Watts, G. (2010). Fenofibrate Concomitantly Decreases Serum Proprotein Convertase Subtilisin/Kexin Type 9 and Very-Low-Density Lipoprotein Particle Concentrations in Statin-treated Type 2 Diabetic Patients. Diabetes, Obesity and Metabolism, 12(9), 752-756. [More Information]
  • Nobecourt, E., Tabet, F., Lambert, G., Puranik, R., Bao, B., Yan, L., Davies, M., Brown, B., Jenkins, A., Dusting, G., Barter, P., Rye, K., et al (2010). Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(4), 766-772. [More Information]
  • Griffin, M., Wilson, L., Mok, Y., Januszewski, A., Wilson, A., Karschimkus, C., Romas, E., Lee, A., Godfrey, T., Wong, M., et al (2010). Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors. Clinical Biochemistry, 43(3), 278-286. [More Information]
  • Valaydon, Z., Lee, P., Dale, G., Januszewski, A., Rowley, K., Nandurkar, H., Karschimkus, C., Best, J., Lyons, T., Jenkins, A. (2009). Increased coated-platelet levels in chronic haemodialysis patients. Nephrology, 14(2), 148-154. [More Information]
  • Kreis, A., Wong, T., Islam, F., Klein, R., Klein, B., Cotch, M., Jenkins, A., Shea, S., Wang, J. (2009). Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes and Vascular Disease Research, 6(1), 40-42. [More Information]
  • Cheung, N., Donaghue, K., Liew, G., Rogers, S., Wang, J., Lim, S., Jenkins, A., Hsu, W., Lee, M., Wong, T. (2009). Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care, 32(1), 106-110. [More Information]
  • Lim, S., Cheung, N., Wang, J., Donaghue, K., Liew, G., Amirul Islam, F., Jenkins, A., Wong, T. (2009). Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes. Diabetes Care, 32(11), 2081-2083. [More Information]
  • Gallego, P., Craig, M., Duffin, A., Bennetts, B., Jenkins, A., Hofer, S., Lam, A., Donaghue, K. (2008). Association Between p.Leu54Met Polymorphism at the Paraoxonase-1 Gene and Plantar Fascia Thickness in Young Subjects With Type 1 Diabetes. Diabetes Care, 31(8), 1585-1589. [More Information]
  • Januszewski, A., Thomas, M., Karschimkus, C., Chung, J., Rowley, K., Nelson, C., ONeal, D., Dragicevic, G., Harper, C., Best, J., et al (2008). Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus. Journal of Medical Investigation, 55(1/2), 29-36. [More Information]
  • Cheung, N., Rogers, S., Donaghue, K., Jenkins, A., Tikellis, G., Wong, T. (2008). Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care, 31(9), 1842-1846. [More Information]
  • Campbell, D., Neal, B., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S., Woodward, M. (2007). Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14(3), 413-418. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2007). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in subjects with cerebrovascular disease. Journal of Hypertension, 25(3), 699-705. [More Information]
  • Nobecourt, E., Davies, M., Brown, B., Curtiss, L., Bonnet, D., Charlton, F., Januszewski, A., Jenkins, A., Barter, P., Rye, K. (2007). The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia: clinical and experimental diabetes and metabolism, 50(3), 643-653. [More Information]
  • Hofer, S., Bennetts, B., Chan, A., Holloway, B., Karschimkus, C., Jenkins, A., Silink, M., Donaghue, K. (2006). Association between PON 1 polymorphisms, PON activity and diabetes complications. Journal of Diabetes and Its Complications, 20(5), 322-328. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S. (2006). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease. European Heart Journal, 27(Suppl 1), 781.
  • Alibrahim, E., Donaghue, K., Rogers, S., Hing, S., Jenkins, A., Chan, A., Wong, T. (2006). Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology, 113(9), 1499-1503. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2006). Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. JAMA Neurology, 63(1), 60-65. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Neal, B., Patel, A., MacMahon, S. (2005). Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons. European Heart Journal, 26(Suppl 1), 257.
  • Woodward, M., Lowe, G., Campbell, D., Colman, S., Rumley, A., Chalmers, J., Neal, B., Patel, A., Jenkins, A., Kemp, B., MacMahon, S. (2005). Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke. Stroke: a journal of cerebral circulation, 36(10), 2143-2147. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease. Hypertension, 45(1), 69-74.
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation, 112(1), 110-116. [More Information]

Conferences

  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2008). Can NT-proBNP Monitoring Help Prevent Cardiovascular Disease? 13th World Congress on Heart Disease, Pianoro (BO) Italy: Medimond International Proceedings.

2014

  • Jenkins, A., McBride, J., Liu, X., Zhang, B., Lee, K., Berry, W., Janknecht, R., Griffin, C., Aston, C., Lyons, T., Ma, J., et al (2014). Elevated Circulation Levels of an Antiangiogenic SERPIN in Patients with Diabetic Microvascular Complications Impair Wound Healing through Suppression of Wnt Signaling. The Journal of Investigative Dermatology, 134, 1725-1734. [More Information]
  • Jenkins, A. (2014). Sometimes you have to give a man a fish. Medical Journal of Australia, 200(2), 122-123. [More Information]
  • Vethakkan, S., Walters, J., Gooley, J., Boston, R., Kay, T., Goodman, D., Jenkins, A., Ward, G. (2014). The incretin response after successful islet transplantation. Transplantation, 97(2), e9-e11. [More Information]

2013

  • Naser, N., Januszewski, A., Brown, B., Jenkins, A., Hill, M., Murphy, T. (2013). Advanced glycation end products acutely impair ca(2+) signaling in bovine aortic endothelial cells. Frontiers in Physiology, 4, 1-14. [More Information]
  • Noonan, J., Jenkins, A., Ma, J., Keech, A., Wang, J., Lamoureux, E. (2013). An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes. Diabetes, 62(12), 3968-3975. [More Information]
  • Brown, B., Nobecourt, E., Zeng, J., Jenkins, A., Rye, K., Davies, M. (2013). Apolipoprotein A-I glycation by Glucose and Reactive Aldehydes Alters Phospholipid Affinity but Not Cholesterol Export from Lipid-Laden Macrophages. PLoS One, 8(5), 1-9. [More Information]
  • Azar, M., Lyons, T., Alaupovic, P., Stoner, J., Quiroga, C., Kaufman, D., Lopes-Virella, M., Klein, R., Jenkins, A. (2013). Apolipoprotein-defined and NMR lipoprotein subclasses in the Veterans Affairs Diabetes Trial. Journal of Diabetes and Its Complications, 27(6), 627-632. [More Information]
  • Jenkins, A., Yu, J., Alaupovic, P., Basu, A., Klein, R., Lopes-Virella, M., Baker, N., Hunt, K., Lackland, D., Garvey, W., et al (2013). Apolipoprotein-defined lipoproteins and apolipoproteins: Associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort. Journal of Diabetes and Its Complications, 27(5), 447-453. [More Information]
  • Jenkins, A., ONeal, D. (2013). Dyslipidaemia in diabetes: a common problem worth treating to target. Endocrinology Today: peer reviewed updates for medical practitioners, 2(2), 24-29.
  • O'Neal, D., Adhya, S., Jenkins, A., Ward, G., Welsh, J., Voskanyan, G. (2013). Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set. Journal of diabetes science and technology, 7(2), 381-388.
  • Seller, D., Scibilia, R., Rodda, C., Jenkins, A. (2013). Growth in insulin pump use in Australian children with Type 1 Diabetes, and subsequent impact on a diabetes camp program. Infusystems Asia, 8(3), 25-30.
  • Hunt, K., Baker, N., Cleary, P., Backlund, J., Lyons, T., Jenkins, A., Virella, G., Lopes-Virella, M. (2013). Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes. Atherosclerosis, 231(2), 315-322. [More Information]
  • Alexander, K., Bryant, W., Cohen, N., Craig, M., Forbes, M., Fulcher, G., Greenaway, T., Harrison, N., Holmes-Walker, J., Howard, G., Jenkins, A., et al (2013). Provision of Quality Care for Adults with Type 1 Diabetes Requiring Insulin Pump Therapy (IIPT). Infusystems Asia, 8(1), 1-6.
  • Rasmussen, B., Hendrieckx, C., Clarke, B., Botti, M., Dunning, T., Jenkins, A., Speight, J. (2013). Psychosocial issues of women with type 1 diabetes transitioning to motherhood: a structured literature review. BMC Pregnancy and Childbirth, 13, 218. [More Information]
  • Samaras, K., Viardot, A., Lee, P., Jenkins, A., Botelho, N., Bakopanos, A., Lord, R., Hayward, C. (2013). Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance. Diabetes and Vascular Disease Research, 10(1), 40-48. [More Information]
  • Campbell, D., Somaratne, J., Jenkins, A., Prior, D., Yii, M., Kenny, J., Newcomb, A., Kelly, D., Black, M. (2013). Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. International Journal of Cardiology, 167(3), 1027-1237. [More Information]
  • Luke, J., Brown, A., Daniel, M., O'Dea, K., Best, J., Jenkins, A., Wang, Z., McDermott, R., Wang, Z., Rowley, K. (2013). Response to the Letter by Kawada et al. regarding the manuscript entitled "The metabolic syndrome and CVD outcomes for a central Australian cohort". Diabetes Research and Clinical Practice, 102(2), e22-e23. [More Information]
  • Du, M., Basu, A., Fu, D., Wu, M., Centola, M., Jenkins, A., Hanssen, K., Garg, S., Hammad, S., Scardo, J., et al (2013). Serum inflammatory markers and preeclampsia in type 1 diabetes: a prospective study. Diabetes Care, 36(7), 2054-2061. [More Information]
  • Bursell, S., Jenkins, A., Brazionisb, L., Rowley, K., Brown, A. (2013). Telehealth in Australia: an evolution in health care services. Medical Journal of Australia, 199(1), 23-24. [More Information]
  • Luke, J., Brown, A., Daniell, M., O'Dea, K., Best, J., Jenkins, A., Wang, Z., McDermott, R., Wang, Z., Rowley, K. (2013). The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Research and Clinical Practice, 100(3), e70-e73. [More Information]
  • Chen, Y., Hu, Y., Lin, M., Jenkins, A., Keech, A., Mott, R., Lyons, T., Ma, J. (2013). Therapeutic Effects of PPARĪ± Agonists on Diabetic Retinopathy in Type 1 Diabetes Models. Diabetes, 62(1), 261-272. [More Information]
  • Jenkins, A., ONeal, D. (2013). What do insulin pumps offer in diabetes care? Endocrinology Today: peer reviewed updates for medical practitioners, 2(4), 27-30.

2012

  • Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]
  • Campbell, D., Somaratne, J., Jenkins, A., Prior, D., Yii, M., Kenny, J., Newcomb, A., Schalkwijk, C., Black, M., Kelly, D. (2012). Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels. PLoS One, 7(11), e49813. [More Information]
  • Lopes-Virella, M., Jenkins, A., Baker, N., Virella, G., Hunt, K., Lyons, T., et al (2012). High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care, 35(6), 1333-1340. [More Information]
  • Ong, K., Rye, K., O'Connell, R., Jenkins, A., Brown, C., Xu, A., Sullivan, D., Barter, P., Keech, A. (2012). Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, 97(12), 4701-4708. [More Information]
  • Januszewski, A., Sachithanandan, N., Karschimkus, C., o'neal, D., Yeung, C., Alkatib, N., Jenkins, A. (2012). Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunction. Diabetic Medicine, 29(6), 726-733. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Shaw, J., Jenkins, A., Wang, J. (2012). Novel versus traditional risk markers for diabetic retinopathy. Diabetologia: clinical and experimental diabetes and metabolism, 55(3), 666-670. [More Information]
  • Januszewski, A., Karschimkus, C., Davis, K., ONeal, D., Ward, G., Jenkins, A. (2012). Plasma 1,5 anhydroglucitol levels, a measure of short-term glycaemia: Assay assessment and lower levels in diabetic vs. non-diabetic subjects. Diabetes Research and Clinical Practice, 95(1), e17-e19. [More Information]
  • Basu, A., Alaupovic, P., Wu, M., Jenkins, A., Yu, Y., Nankervis, A., Hanssen, K., Scholz, H., Henriksen, T., Lorentzen, B., et al (2012). Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. Journal of Clinical Endocrinology and Metabolism, 97(5), 1752-1762. [More Information]
  • Sasongko, M., Wong, T., Donaghue, K., Cheung, N., Jenkins, A., Benitez-Aguirre, P., Wang, J. (2012). Retinal Arteriolar Tortuosity is Associated With Retinopathy and Early Kidney Dysfunction in Type 1 Diabetes. American Journal of Ophthalmology, 153(1), 176-183. [More Information]
  • Benitez-Aguirre, P., Sasongko, M., Craig, M., Jenkins, A., Cusumano, J., Cheung, N., Wong, T., Donaghue, K. (2012). Retinal vascular geometry predicts incident renal dysfunction in young people with type 1 diabetes. Diabetes Care, 35(3), 599-604. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Kawasaki, R., Jenkins, A., Shaw, J., Robinson, C., Wang, J. (2012). Serum Apolipoproteins are Associated With Systemic and Retinal Microvascular Function in People With Diabetes. Diabetes, 61(7), 1785-1792. [More Information]
  • Bursell, S., Brazionis, L., Jenkins, A. (2012). Telemedicine and ocular health in diabetes mellitus. Clinical & Experimental Optometry, 95(3), 311-327. [More Information]

2011

  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2011). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(2), 280-290.
  • Tabet, F., Lambert, G., Torres, L., Hou, L., Sotirchos, I., Touyz, R., Jenkins, A., Barter, P., Rye, K. (2011). Lipid-Free Apolipoprotein A-I and Discoidal Reconstituted High-Density Lipoproteins Differentially Inhibit Glucose-Induced Oxidative Stress in Human Macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 1192-1200. [More Information]
  • Benitez-Aguirre, P., Craig, M., Sasongko, M., Jenkins, A., Wong, T., Wang, J., Cheung, N., Donaghue, K. (2011). Retinal Vascular Geometry Predicts Incident Retinopathy in Young People With Type 1 Diabetes. Diabetes Care, 34(7), 1622-1627. [More Information]
  • Sasongko, M., Wong, T., Nguyen, T., Kawasaki, R., Jenkins, A., Shaw, J., Wang, J. (2011). Serum Apolipoprotein AI and B Are Stronger Biomarkers of Diabetic Retinopathy Than Traditional Lipids. Diabetes Care, 34(2), 474-479. [More Information]

2010

  • Sasongko, M., Wang, J., Donaghue, K., Cheung, N., Benitez-Aguirre, P., Jenkins, A., Hsu, W., Lee, M., Wong, T. (2010). Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care, 33(6), 1331-1336. [More Information]
  • Davis, T., Ting, R., Best, J., Donoghoe, M., Drury, P., Sullivan, D., Jenkins, A., O'Connell, R., Whiting, M., Glasziou, P., Simes, R., Gebski, V., Keech, A., et al (2010). Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia: clinical and experimental diabetes and metabolism, 54(2), 280-290. [More Information]
  • Chan, D., Hamilton, S., Rye, K., Chew, G., Jenkins, A., Lambert, G., Watts, G. (2010). Fenofibrate Concomitantly Decreases Serum Proprotein Convertase Subtilisin/Kexin Type 9 and Very-Low-Density Lipoprotein Particle Concentrations in Statin-treated Type 2 Diabetic Patients. Diabetes, Obesity and Metabolism, 12(9), 752-756. [More Information]
  • Nobecourt, E., Tabet, F., Lambert, G., Puranik, R., Bao, B., Yan, L., Davies, M., Brown, B., Jenkins, A., Dusting, G., Barter, P., Rye, K., et al (2010). Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(4), 766-772. [More Information]
  • Griffin, M., Wilson, L., Mok, Y., Januszewski, A., Wilson, A., Karschimkus, C., Romas, E., Lee, A., Godfrey, T., Wong, M., et al (2010). Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors. Clinical Biochemistry, 43(3), 278-286. [More Information]

2009

  • Valaydon, Z., Lee, P., Dale, G., Januszewski, A., Rowley, K., Nandurkar, H., Karschimkus, C., Best, J., Lyons, T., Jenkins, A. (2009). Increased coated-platelet levels in chronic haemodialysis patients. Nephrology, 14(2), 148-154. [More Information]
  • Kreis, A., Wong, T., Islam, F., Klein, R., Klein, B., Cotch, M., Jenkins, A., Shea, S., Wang, J. (2009). Is nuclear magnetic resonance lipoprotein subclass related to diabetic retinopathy? The Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes and Vascular Disease Research, 6(1), 40-42. [More Information]
  • Cheung, N., Donaghue, K., Liew, G., Rogers, S., Wang, J., Lim, S., Jenkins, A., Hsu, W., Lee, M., Wong, T. (2009). Quantitative assessment of early diabetic retinopathy using fractal analysis. Diabetes Care, 32(1), 106-110. [More Information]
  • Lim, S., Cheung, N., Wang, J., Donaghue, K., Liew, G., Amirul Islam, F., Jenkins, A., Wong, T. (2009). Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes. Diabetes Care, 32(11), 2081-2083. [More Information]

2008

  • Gallego, P., Craig, M., Duffin, A., Bennetts, B., Jenkins, A., Hofer, S., Lam, A., Donaghue, K. (2008). Association Between p.Leu54Met Polymorphism at the Paraoxonase-1 Gene and Plantar Fascia Thickness in Young Subjects With Type 1 Diabetes. Diabetes Care, 31(8), 1585-1589. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2008). Can NT-proBNP Monitoring Help Prevent Cardiovascular Disease? 13th World Congress on Heart Disease, Pianoro (BO) Italy: Medimond International Proceedings.
  • Januszewski, A., Thomas, M., Karschimkus, C., Chung, J., Rowley, K., Nelson, C., ONeal, D., Dragicevic, G., Harper, C., Best, J., et al (2008). Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus. Journal of Medical Investigation, 55(1/2), 29-36. [More Information]
  • Cheung, N., Rogers, S., Donaghue, K., Jenkins, A., Tikellis, G., Wong, T. (2008). Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care, 31(9), 1842-1846. [More Information]

2007

  • Campbell, D., Neal, B., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S., Woodward, M. (2007). Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. European Journal of Cardiovascular Prevention and Rehabilitation, 14(3), 413-418. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2007). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in subjects with cerebrovascular disease. Journal of Hypertension, 25(3), 699-705. [More Information]
  • Nobecourt, E., Davies, M., Brown, B., Curtiss, L., Bonnet, D., Charlton, F., Januszewski, A., Jenkins, A., Barter, P., Rye, K. (2007). The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase. Diabetologia: clinical and experimental diabetes and metabolism, 50(3), 643-653. [More Information]

2006

  • Hofer, S., Bennetts, B., Chan, A., Holloway, B., Karschimkus, C., Jenkins, A., Silink, M., Donaghue, K. (2006). Association between PON 1 polymorphisms, PON activity and diabetes complications. Journal of Diabetes and Its Complications, 20(5), 322-328. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Patel, A., MacMahon, S. (2006). Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease. European Heart Journal, 27(Suppl 1), 781.
  • Alibrahim, E., Donaghue, K., Rogers, S., Hing, S., Jenkins, A., Chan, A., Wong, T. (2006). Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology, 113(9), 1499-1503. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2006). Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. JAMA Neurology, 63(1), 60-65. [More Information]

2005

  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Neal, B., Patel, A., MacMahon, S. (2005). Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons. European Heart Journal, 26(Suppl 1), 257.
  • Woodward, M., Lowe, G., Campbell, D., Colman, S., Rumley, A., Chalmers, J., Neal, B., Patel, A., Jenkins, A., Kemp, B., MacMahon, S. (2005). Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke. Stroke: a journal of cerebral circulation, 36(10), 2143-2147. [More Information]
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Heart Failure by Amino Terminal-pro-B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease. Hypertension, 45(1), 69-74.
  • Campbell, D., Woodward, M., Chalmers, J., Colman, S., Jenkins, A., Kemp, B., Neal, B., Patel, A., MacMahon, S. (2005). Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease. Circulation, 112(1), 110-116. [More Information]

2003

  • Jenkins, A., Breen, R., Lindsay, R., Brew, A. (2003). Reshaping Teaching In Higher Education: Linking Teaching With Research. UK: RoutledgeFalmer imprint of Taylor & Francis.

To update your profile click here. For support on your academic profile contact .